Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,204,533 papers from all fields of science
Search
Sign In
Create Free Account
3-hydroxypyridin-2-one
Known as:
CP02 indium
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Pyridones
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Copper(II) bis(4,4,4-trifluoro-1-phenylbutane-1,3-dionate) complexes with pyridin-2-one, 3-hydroxypyridine and 3-hydroxypyridin-2-one ligands: molecular structures and hydrogen-bonded networks.
F. Perdih
Acta Crystallographica Section C Structural…
2017
Corpus ID: 4231731
Copper(II) bis(4,4,4-trifluoro-1-phenylbutane-1,3-dionate) complexes with pyridin-2-one (pyon), 3-hydroxypyridine (hpy) and 3…
Expand
2015
2015
1S-Cp02 本格芋焼酎の造りと味わい(学生および市民フォーラム九州学生本格焼酎プログラム(焼酎の製造/歴史,アルコールの効能そして飲用の楽しさを伝える),シンポジウム)
田中 智彦
2015
Corpus ID: 183823808
2014
2014
1S-Cp02 哺乳動物の腸内エコシステムがもたらす生体恒常性維持機構(シンセティック・エコロジー: 腸内から自然環境の恒常的維持に向けた微生物生態系の調和,シンポジウム)
福田 真嗣
2014
Corpus ID: 82142692
2014
2014
TRASTORNO DE PÁNICO. DISEÑO Y VALIDACIÓN DE UN INSTRUMENTO PARA SU EVALUACIÓN
M. Pérez
,
Paola Morandi
,
S. Quesada
2014
Corpus ID: 192521334
El presente trabajo se enmarca en el desarrollo del proyecto UBACyT CP02:“Evaluacion de modalidades de intervencion en el ambito…
Expand
2013
2013
1S-Cp02 代謝パスウェイデータベースからの知識抽出(代謝工学がもたらした"ものづくり"と今後求められる技術,シンポジウム)
荒木 通啓
2013
Corpus ID: 195592491
1994
1994
Platelet labelling with indium-hydroxypyridinone and indium-hydroxypyranone complexes
R. D. Abeysinghe
,
B. Ellis
,
R. Hider
,
J. Porter
European Journal of Nuclear Medicine
1994
Corpus ID: 20474360
In order to identify new compounds which label platelets without affecting their function, three classes of metal chelating…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE